Take a fresh look at your lifestyle.

Bharat Biotech submits Covaxin phase 3 trials data to DCGI

Bharat Biotech has submitted data from phase 3 trials of the Covaxin vaccine to the Drugs Controller General of India (DCGI). Covaxin is among three vaccines being used in the nationwide drive against Covid-19.

Midle of the post

It was granted approval by the DCGI in January, along with the Oxford University-AstraZeneca Vaccine which is being manufactured by the Pune-based Serum Institute of India (SII) as Covishield.

A third vaccine, Russia’s Sputnik V, was also granted emergency use authorisation (EUA) in April.

Leave A Reply

Your email address will not be published.